Literature DB >> 8316652

Probability of radiation-induced complications in normal tissues with parallel architecture under conditions of uniform whole or partial organ irradiation.

E D Yorke1, G J Kutcher, A Jackson, C C Ling.   

Abstract

A biologically based model is developed for normal tissue complication probability as a function of dose and irradiated volume fraction for organs such as the kidney and the lung. The organ is assumed to be composed of functional subunits (FSUs) which are arranged in a parallel architecture. The complication is produced only if a sufficiently large fraction of the FSUs are inactivated by radiation and an FSU is inactivated only when all the clonogenic cells within it are killed. The linear-quadratic model is used for the dose-response of individual cells within an FSU. The predictions of this model are compared with those of an empirical power law function for uniform whole and partial organ irradiation.

Entities:  

Mesh:

Year:  1993        PMID: 8316652     DOI: 10.1016/0167-8140(93)90264-9

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  11 in total

1.  Quantitative Analyses of Normal Tissue Effects in the Clinic (QUANTEC): an introduction to the scientific issues.

Authors:  Søren M Bentzen; Louis S Constine; Joseph O Deasy; Avi Eisbruch; Andrew Jackson; Lawrence B Marks; Randall K Ten Haken; Ellen D Yorke
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-03-01       Impact factor: 7.038

2.  Sparing level Ib lymph nodes by intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma.

Authors:  Jing Chen; Dan Ou; Xiayun He; Chaosu Hu
Journal:  Int J Clin Oncol       Date:  2013-12-12       Impact factor: 3.402

3.  Modeling age-dependent radiation-induced second cancer risks and estimation of mutation rate: an evolutionary approach.

Authors:  Kamran Kaveh; Venkata S K Manem; Mohammad Kohandel; Siv Sivaloganathan
Journal:  Radiat Environ Biophys       Date:  2014-11-18       Impact factor: 1.925

4.  Correction of arterial input function in dynamic contrast-enhanced MRI of the liver.

Authors:  Hesheng Wang; Yue Cao
Journal:  J Magn Reson Imaging       Date:  2012-03-05       Impact factor: 4.813

5.  Local and Global Function Model of the Liver.

Authors:  Hesheng Wang; Mary Feng; Andrew Jackson; Randall K Ten Haken; Theodore S Lawrence; Yue Cao
Journal:  Int J Radiat Oncol Biol Phys       Date:  2015-10-09       Impact factor: 7.038

6.  Radiation-Induced Liver Injury in Three-Dimensional Conformal Radiation Therapy (3D-CRT) for Postoperative or Locoregional Recurrent Gastric Cancer: Risk Factors and Dose Limitations.

Authors:  Guichao Li; Jiazhou Wang; Weigang Hu; Zhen Zhang
Journal:  PLoS One       Date:  2015-08-20       Impact factor: 3.240

Review 7.  Modeling Radiotherapy Induced Normal Tissue Complications: An Overview beyond Phenomenological Models.

Authors:  Marco D'Andrea; Marcello Benassi; Lidia Strigari
Journal:  Comput Math Methods Med       Date:  2016-12-01       Impact factor: 2.238

8.  Functional Data Analysis Applied to Modeling of Severe Acute Mucositis and Dysphagia Resulting From Head and Neck Radiation Therapy.

Authors:  Jamie A Dean; Kee H Wong; Hiram Gay; Liam C Welsh; Ann-Britt Jones; Ulrike Schick; Jung Hun Oh; Aditya Apte; Kate L Newbold; Shreerang A Bhide; Kevin J Harrington; Joseph O Deasy; Christopher M Nutting; Sarah L Gulliford
Journal:  Int J Radiat Oncol Biol Phys       Date:  2016-08-22       Impact factor: 7.038

9.  Comparison of dose response models for predicting normal tissue complications from cancer radiotherapy: application in rat spinal cord.

Authors:  Magdalena Adamus-Górka; Panayiotis Mavroidis; Bengt K Lind; Anders Brahme
Journal:  Cancers (Basel)       Date:  2011-05-18       Impact factor: 6.639

10.  Comparing conformal, arc radiotherapy and helical tomotherapy in craniospinal irradiation planning.

Authors:  Pamela A Myers; Panayiotis Mavroidis; Nikos Papanikolaou; Sotirios Stathakis
Journal:  J Appl Clin Med Phys       Date:  2014-09-08       Impact factor: 2.102

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.